Save on this medicine
Other brands with the same active ingredient
These brands contain the same active ingredient (Vericiguat). Same strength and form. Confirm the switch with your doctor or pharmacist.
Indications & Uses
VERIVAS 5 is indicated for:
Dosage Reference
Reference Information Only
Dosages shown are general references from official sources. Always consult your doctor or pharmacist for personalized dosing.
Adults:
Recommended Starting Dose: The recommended starting dose of Vericiguat is 2.5 mg orally once daily with food. Double the dose of Vericiguat approximately every 2 weeks to reach the target maintenance dose of 10 mg once daily, as tolerated by the patient. For patients who are unable to swallow whole tablet, Vericiguat may be crushed and mixed with water immediately before administration or as directed by physician.Geriatric Patients: No dosage adjustment of Vericiguat is required in geriatric patients. No overall differences in safety or efficacy of Vericiguat were observed between patients aged 65 years and older compared to younger patients, but greater sensitivity of some older individuals cannot be ruled out.Hepatic Impairment: No dosage adjustment of Vericiguat is recommended in patients with mild or moderate hepatic impairment.Renal Impairment: No dosage adjustment of Vericiguat is recommended in patients with estimated glomerular filtration rate (eGFR) ≥15 mL/min/1.73m2 who are not on dialysis. Vericiguat has not been studied in patients with eGFR <15 mL/min/1.73m2 at treatment initiation or on dialysis.Use in Children & Adolescents: Safety and effectiveness of Vericiguat have not been established in pediatric patients.
Side Effects
Common Side effects: The most common side effects of Capazi tablet include low blood pressure & low red blood cells (Anemia).
Cautions & Contraindications
Warnings & Precautions
Capazi should not be administered to a pregnant female because it may cause fetal harm. Obtain a pregnancy test in females of reproductive potential prior to initiating treatment with Capazi. Pregnancy should be excluded before the start of treatment. To prevent pregnancy, females of reproductive potential must use effective forms of contraception during treatment and for one month after stopping treatment.
Contraindications
Vericiguat is contraindicated in patients with concomitant use of other soluble guanylate cyclase (sGC) stimulators.